Advertisement

Topics

GSK buoyed as another generic Advair blocked, HIV treatment meets goals

05:17 EDT 14 Jun 2018 | FinanzNachrichten

GlaxoSmithKline shares were given a double boost on Thursday as the drugmaker said its two-drug treatment for HIV had met main targets in late-stage studies, while news also emerged that one potent...

Original Article: GSK buoyed as another generic Advair blocked, HIV treatment meets goals

NEXT ARTICLE

More From BioPortfolio on "GSK buoyed as another generic Advair blocked, HIV treatment meets goals"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...